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Abstract
Persistence of multiple variants of rabies virus in wild Chiroptera and Carnivora presents a continuing challenge to medical, veterinary and
wildlife management professionals. Oral rabies vaccination (ORV) targeting specific Carnivora species has emerged as an integral adjunct to
conventional rabies control strategies to protect humans and domestic animals. ORV has been applied with progress toward eliminating rabies
in red foxes (Vulpes vulpes) in western Europe and southern Ontario, Canada. More recently since 1995, coordinated ORV was implemented
among eastern states in the U.S.A. to prevent spread of raccoon (Procyon lotor) rabies and to contain and eliminate variants of rabies virus in
the gray fox (Urocyon cinereoargenteus) and coyote (Canis latrans) in Texas. In this paper, we describe the current cooperative ORV program
in the U.S.A. and discuss the importance of coordination of surveillance and rabies control programs in Canada, Mexico and the U.S.A.
Specifically, several priorities have been identified for these programs to succeed, which include additional oral vaccines, improved baits to
reach target species, optimized ORV strategies, effective communication and legal strategies to limit translocation across ORV barriers, and
access to sufficient long-term funding. These key priorities must be addressed to ensure that ORV has the optimal chance of achieving long
range programmatic goals of eliminating specific variants of rabies virus in North American terrestrial carnivores.
© 2005 Elsevier B.V. All rights reserved.
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1. Introduction
In countries where the control of canine rabies has been
achieved, wildlife serves as a dominant reservoir. Modern
prevention and control techniques for wildlife rabies may
serve as a model for intervention with other zoonotic dis-
eases. Oral rabies vaccination (ORV) was proven feasi-
ble in captive red foxes in the U.S. in 1969 (Baer et al.,
1971). Thereafter, ORV targeting rabies in red foxes be-
gan in Europe in 1977 (Steck et al., 1982), and contin-
ues in several Europeans countries with the goal of disease
elimination (Aubert et al., 1994; Stohr and Meslin, 1996;
Wandeler, 2000; Zanoni et al., 2000). ORV was initiated in
Ontario, Canada in 1989 (MacInnes et al., 2001) and contin-
ues with the goal of eliminating an artic fox (Alopex lagopus)
variant of rabies virus in red foxes (MacInnes and LeBer,
2000).
Experimental ORV programs began in the U.S.A. in the
mid-1990s (Bigler, 1997; Robbins et al., 1998; Fearneyhough
et al., 1998; Smith et al., 1999; Olson et al., 2000; USDA,
2003) after field safety and efficacy trials were successfully
completed on Parramore Island, Virginia in 1990 (Hanlon
et al., 1998) and near Williamsport, Pennsylvania in 1991
(Hanlon and Rupprecht, 1998) and Cape May, New Jersey
from 1992 and 1993 (Roscoe et al., 1998). Federal support
for coordinated ORV has provided the impetus to establish co-
operative programs in 15 eastern states to prevent the spread
of raccoon rabies and to create programs in Texas to prevent
rabies in coyotes and a unique variant of rabies in gray foxes.
While these programs show promise, several challenges need
to be addressed to better ensure that the long-term program-
matic goal of rabies elimination in terrestrial wildlife may be
achieved. In this paper, we discuss the current status of ORV
in the U.S.A., initiatives to address challenges facing ORV,
and the role of international cooperation and coordination
with Canada and Mexico in meeting North American rabies
management goals.
2. Recent history and current status of ORV in the
United States
In 1998, the U.S. Department of Agriculture, Animal and
Plant Health Inspection Service, Wildlife Services (APHIS-
WS) received its first federal appropriation to cooperate
in existing ORV projects, expand ORV to states of strate-
gic importance in preventing the spread of specific terres-
trial variants of the rabies virus, and to assist in coordi-
nating cooperative interstate ORV projects. The first initia-
tive taken to meet these objectives was to form a National
Rabies Management Team, composed of diverse expertise
from State agencies responsible for public health, agricul-
ture, and wildlife, Centers for Disease Control and Preven-
tion (CDC) and other Federal agencies and universities to
strategically plan, establish program priorities and goals, and
evaluate program progress. This National Rabies Manage-
Table 1
Ten interdisciplinary teams within the National Rabies Management Team
charged with evaluating critical ORV subject areas and providing recom-
mendations for cooperative rabies control planning
Baiting support: air and ground
Baiting strategies/GIS planning
Communications planning
Contingency action planning
Economic analysis
NEPA compliance
ORV evaluation
Research prioritization
Surveillance/laboratory support
Vaccine/bait/biomarker
ment Team is composed of 10 focus teams charged with pro-
viding guidance and recommendations for topics integral to
national ORV, ranging from National Environmental Policy
Act (NEPA [NEPA, 1969]) compliance to research prioriti-
zation (Table 1).
Between 1998 and 2003, ORV expanded from New York,
Ohio, Texas and Vermont (smaller programs were also in
place in Florida, Maryland, and Massachusetts) to include
16 states (Figs. 1 and 2). Vaccination zones were integrated
with natural geographic features such as large lakes, rivers
and poorer raccoon habitats at high elevations where prac-
tical to bolster vaccination barriers and reduce the overall
cost of rabies control. By 2003, increased federal support
had facilitated nearly full implementation of the containment
barrier for raccoon rabies in the eastern U.S. In addition, ap-
proximately 96 km of western Pennsylvania had been treated
where raccoon rabies has been enzootic for over a decade.
This extension is designed to explore strategies to eliminate
the raccoon variant of rabies virus. ORV was implemented
to eliminate canine rabies (spread predominantly by coyotes)
from south Texas. This goal was achieved in 2000, but a 65 km
wide maintenance vaccination barrier has been created along
the Rio Grande to prevent re-infection from Mexico. This
barrier was challenged in 2001 and 2004, underscoring its
importance especially in the absence of more comprehensive
rabies surveillance in the region. The containment barrier for
gray fox rabies that was created solely with state funding
in 1996 in west-central Texas was also restored with federal
support to make up for decreased state funding. In 2003, ap-
proximately 180,000 km2 were treated with over 10 million
vaccine-ladened baits in 16 states to target variants of rabies
virus unique to the raccoon and gray fox, as well as the canine
strain in coyotes along Texas–Mexico border (Figs. 1 and 2;
Table 2).
The vision for the National ORV Program is to eliminate
rabies in terrestrial carnivores. The immediate goals are to
prevent specific variants of rabies virus in the raccoon and
gray fox (strain unique to Texas) from spreading to new, un-
infected areas (Slate et al., 2002). The long-range goal is to
eliminate these variants from the U.S.A. as has been accom-
plished with rabies in the coyote in south Texas. Elimination
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Fig. 1. Trends for the number of cooperating states, oral rabies baits distributed and area treated in the United States from 1995 to 2004.
is expected to be challenging, in part, because specific rabies
virus variants may have been established for long periods
of time in some geographic areas (e.g., raccoon rabies was
first described in 1947 in Florida [Bigler et al., 1973]). Ad-
ditional hurtles to success include the presence of a diverse
meso-carnivore complex that serves as a reservoir for specific
variants of the rabies virus and the presence of extraordinarily
high densities of raccoons, in particular, that not infrequently
occur in response to intentional feeding or access to human
refuse that may facilitate rapid spread of rabies. True elimi-
nation cannot be achieved without international cooperation
from Canada and Mexico. This task is much more formidable
than the focus on ORV in the red fox alone, as conducted to
date.
3. Programmatic challenges and initiatives
3.1. Need for additional oral rabies vaccines
Raboral V-RG® is the only oral rabies vaccine licensed for
use in the U.S. It has not produced sufficient levels of pop-
ulation immunity in skunks (primarily Mephitis mephitis) in
the wild at the current dose (≥107.7 TCID50/ml), and V-RG
may be less effective in skunks than other species (Tolson
et al., 1987). Skunks are a major contributor to rabies in
North America. Thirty-eight percent of cases associated with
the raccoon variant of rabies virus involved skunks in 2001
(Krebs et al., 2002), a trend that has raised concerns about an
independent maintenance cycle for raccoon rabies in skunks
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Fig. 2. Oral vaccination zones targeting raccoon, gray fox (in Texas) and canine (coyotes) variant of the rabies virus in the United States in 2004.
Table 2
Summary of ORV bait distribution by species and state for 2003
State Area baited (km2) No. of baits distributed
Raccoon
AL 3215 175839
FL 6293 500507
GA 1058 69317
ME 4308 276104
MA 420 54822
NH 385 18140
NJ Cape May Co. 39000
NY 19657 1367777
OH 8156 621148
PA 24900 2002005
TN 3232 231865
VA 5669 389667
VT 6403 327405
WV 25356 1702585
Coyote
TX 31080 700000
Gray fox
TX 49210 1800000
Totals 189342 10276181
(Guerra et al., 2003). The striped skunk may also help main-
tain the arctic fox variant (in red foxes) in southern Ontario
(Nadin-Davis et al., 1999). The national rabies management
goals of virus containment and elimination will likely remain
elusive until an oral vaccine is licensed that is immunogenic
in all terrestrial rabies reservoir species. In addition, skunk ra-
bies virus, which has the broadest geographic distribution of
all terrestrial rabies variants in the U.S.A. (Krebs et al., 1995)
can currently be addressed only though local trap-vaccinate-
release (TVR) or population suppression programs.
At the close of 2003, almost 50 million doses of Raboral
V-RG® had been distributed across broad and diverse land-
scapes during the past decade with only one human vaccinia
virus infection that resolved without lasting medical effects
(Rupprecht et al., 2001). In spite of this field safety record,
vaccinia virus, the vector for the rabies virus glycoprotein
gene in Raboral V-RG®, is in the family Poxiviridae (Van
Regenmortel et al., 2000), which includes viruses that have
come under greater scrutiny because of smallpox bioterror-
ism concerns (CDC, 2003a) and recent public health inci-
dents involving monkeypox (CDC, 2003b). In addition, lack
of competing vaccine manufacturers for V-RG or other ef-
fective licensed vaccines may potentially impede business
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incentives for product improvements and competitive pric-
ing.
In recognition of these critical issues, the Vaccine Team
met in April 2003 to assess prospective oral vaccine candi-
dates and potential regulatory obstacles. Funding was pro-
vided in 2003 to explore canine adenovirus (CAdV-2) (Van
Regenmortel et al., 2000) as a vector for the rabies virus
glycoprotein gene. Research has been underway since 2000
in Ontario on a human adenovirus (HAdV-5) as a poten-
tial vector for the rabies glycoprotein gene (Yarosh et al.,
1996). In addition, there are other prospective recombinant
and non-recombinant vaccines that may show promise for all
terrestrial rabies reservoir species (Dietzschold et al., 2003).
Development, safety and efficacy testing, and licensure of ad-
ditional oral vaccines that are effective in all terrestrial rabies
reservoir species remain among the highest priorities of the
National Rabies Management Team.
3.2. Current bait options and future needs
Raboral V-RG® is currently delivered to rac-
coons in an extruded fishmeal polymer (FMP) bait
(3.18 cmH× 3.18 cmL× 1.91 cmW) containing 150 mg
(1% of the 15 g bait) of tetracycline hydrochloride as a bone
and tooth biomarker (MERIAL Ltd., Athens, Georgia). A
plastic sachet containing 1.8 ml of Raboral-V-RG® is affixed
within the hollow of the hardened extruded bait by a wax
plug. The same bait–vaccine combination is used in ORV
programs targeting coyotes. An extruded, poultry-based,
dog food polymer bait (otherwise identical to the fishmeal
bait–vaccine combination) is used in ORV programs tar-
geting gray foxes. A coated sachet (CS) bait, identical to
the FMP sachet but coated directly with fishmeal, is also
being evaluated in ORV programs in the northeastern U.S.A.
Field and captive testing continues with the MERIAL FMP
cylindrical bait, an Ontario bait (Artemis Technologies Inc.,
Guelph, Ont., Canada), and other viable candidates.
To ensure maximum immune levels in target populations,
baits are needed that are attractive to target species and also
facilitate puncture of the sachet or alternative vaccine con-
tainers when chewed. Ideally, a single bait would be available
that possesses the requisite favorable attributes (Table 3) to
reach all terrestrial rabies reservoir species with an equally
high level of effectiveness. Given that the terrestrial rabies
reservoirs include the striped skunk, raccoon, red and gray
foxes, and coyote, differing foraging behaviors and animal
size (physical capability for handling and chewing differ-
ent size and shapes of baits), as well as the presence of dif-
ferent age cohorts in target populations (juvenile, sub-adult
and adult) may require the availability of more than one bait
option. Currently, MERIAL’s CS appears to offer the best
promise, at least as an interim bait, to reach all target species;
however, additional captive and field studies are required and
underway. Also, current production capability remains unre-
solved to meet potential market demand for the CS at this
time.
Table 3
Optimal oral rabies bait characteristics
Size
Shape
Consistency
Attractive and persistent flavor
Attractive and persistent odor
Visible to rabies reservoir species
Invisible to non-targets and humans
Stable, does not melt or spoil
Matrix can withstand aerial drop
Matrix protects against vaccine leakage and from exposure to UV
light
Mass not sufficient to cause injury or property damage from aerial
distribution
Easily used for both aerial (rotary and fixed-wing) and hand baiting
18 month shelf-life without bait or biomarker degradation
Target species specific/terrestrial rabies reservoir specific
Can be surface-labeled
Food grade safe
Could be consumed by dogs without complication
Ideal bait matrix might combine both the vaccine and biomarker
Inexpensively mass produced
3.3. Strategy considerations for ORV targeting
terrestrial carnivores
Access to highly immunogenic oral vaccines, together
with optimal baits for their delivery, are critical strategic com-
ponents to ORV. Nevertheless, there is a myriad of spatial,
temporal, environmental and other issues that also impact
ORV effectiveness. Although it is not within the scope of this
paper to discuss these in detail, some of the more important
strategy issues include: time of year to conduct ORV, annual
frequency of ORV, bait density, baiting distribution patterns,
non-target competition for baits, and habitat-specific prefer-
ences of reservoir species. The presence of extraordinarily
high population densities of raccoons (Riley et al., 1998) and
other rabies reservoir species, often in suburban or park set-
tings, will continue to represent a strong challenge to achiev-
ing rabies management goals. Meeting long-range goals may
require a paradigm shift from ORV as a single tactic toward
evaluation of integrated strategies that may include contra-
ception, reduction in access to food subsidies (i.e., reduced
habitat carrying capacity for rabies reservoir species in spe-
cific environments) and focal population suppression. While
studies have focused on some of these issues in North Amer-
ica, site specific and regional influences associated with these
variables are not well documented.
3.4. Potential for rabies translocation
Prior to 1977, raccoon rabies was confined to the south-
eastern U.S., primarily Florida and Georgia (Bigler et al.,
1973). From 1977 to mid-1983, a total of 1608 raccoon ra-
bies cases was reported from Washington, D.C. and West
Virginia, Virginia, Maryland and Pennsylvania (Beck, 1984).
The probable origin of this epizootic was the translocation of
raccoons infected with rabies from the southeastern U.S., to
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the mid-Atlantic region, where the raccoon variant of rabies
virus had not previously been reported (Nettles et al., 1979).
Results from monoclonal antibody analysis of virus samples
from the mid-Atlantic region of the U.S.A. were identical to
the variant of rabies virus obtained from rabid raccoons in
the southeastern states of the U.S.A. (Smith et al., 1984).
Translocation of raccoons or other rabies reservoir species
can accelerate the rate of spread for rabies (as well as other
diseases) and seriously jeopardize intervention strategies
with ORV designed to create immune buffer zones to con-
tain rabies spread (Smith et al., 2002). Translocation could
undermine the commitment of tens of millions of dollars in
state, provincial and federal funds to prevent raccoon or other
variants of rabies from spreading.
The Communications Planning Team has taken the ini-
tiative to work closely with state wildlife, agriculture and
public health officials to develop communication strategies
to reach key audiences such as dog trainers, hunters, trappers,
nuisance wildlife control operators, and wildlife rehabilita-
tors on the negative impacts of translocation. The immediate
goal is to reduce translocation of rabies reservoir species in
the proximity of ORV zones. This will be a daunting task as
translocation, in spite of its many potentially negative conse-
quences (Frampton and Webb, 1973; Wright, 1977; Nettles
et al., 1979; Talyor and Pelton, 1979; Rosatte and MacInnes,
1989; Mosillo et al., 1999), has become a common practice
in many areas of North America (Craven et al., 1998).
3.5. Bat rabies—a potential confounding rabies control
factor
The prospect of effective ORV programs for insectivorous
bats appears remote at this time, given the need for novel, co-
ordinated strategies to reach commensal species. For exam-
ple, bats have virtually unlimited access to refuge in houses
and other dwellings, and this is but one of several challenges.
Nevertheless, transmission of rabies from bats to terrestrial
carnivores may be the source for some extant rabies variants
in carnivores (Badrane and Tordo, 2001), adding to the com-
plexity of achieving long-term rabies management goals for
terrestrial rabies. Documentation of big brown bat (Eptesicus
fuscus) rabies virus spillover into skunks near Flagstaff, Ari-
zona, with up to 19 skunks infected prior to intervention of the
TVR (Engeman et al., 2003), represented an unprecedented
contemporaneous event supporting the thesis that terrestrial
rabies variants could evolve from virus host shifts from bats
to terrestrial carnivores (Badrane and Tordo, 2001; Hughes et
al., 2004). Adequate enhanced surveillance (i.e., beyond pub-
lic health surveillance focused on potential or actual human
exposures to the rabies virus) and differential virus strain di-
agnosis in bats and carnivores will continue to be required to
trigger implementation of ORV contingency plans to address
potential emergence of new terrestrial variants of the rabies
virus.
3.6. Economic basis for rabies funding
Large-scale ORV began with state funded programs in
Texas in 1995 (Fearneyhough et al., 1998) and Ohio in 1997
(Smith et al., 1999). Incremental successes in eliminating
coyote rabies in Texas (Fearneyhough et al., 1998) and in pre-
venting the westward spread of raccoon rabies through Ohio
were catalysts for increased federal funding, which led to
more diverse partnerships involving additional states, CDC,
APHIS-WS and universities. Federal funding is critical to
provide the necessary expertise, resources and coordination
among states that have varying levels of rabies infrastructure
and funding.
ORV is expensive to implement. Costs are incurred for bait
production, air time for bait deployment, fuel, ground baiting,
surveillance, and project planning and evaluation. Costs are
dominated by the unit cost of bait/vaccine, currently priced at
$1.27/FMP bait or $1.00/CS. Based on 2003 contracts for the
distribution for 4.23 million baits targeting raccoons along the
Appalachian Ridge, which includes portions of Pennsylvania,
Ohio, Maryland, West Virginia, Virginia and Tennessee, bait,
air time and fuel costs were $5.38, $0.69, and $0.11 millions,
respectively (Table 4). Costs were $96/km2 for areas treated
at an actual mean bait density of 66/km2; target bait density
was 75/km2. Current average costs for these critical strate-
gic components are lower than previously reported estimates
(Uhaa et al., 1992; Foroutan et al., 2002; Kemere et al., 2002)
in large part as a result of the recent expanded scope of ORV,
which facilitated negotiation of more favorable contract pric-
ing.
Benefits are largely driven by the expected savings from
reduced costs associated with the burden of disease, such
as minimizing exposure from fewer rabid animal encoun-
Table 4
Summary of costs for baits, air time and fuel to aerially distribute 4.23 million oral rabies vaccine baits along the Appalachian Ridge barrier in 2003 (baits cost
$1.27 each)
State No. of baits distributed Bait ($) Air time ($) Fuel ($) Area treated (km2)
MD 47711 60593 13829 1722 689
OH 536908 681873 86928 12208 8156
PA 1421517 1805327 246847 33922 21518
TN 180000 228600 32343 6447 2734
VA 373227 473998 56729 11108 5669
WV 1674505 2126621 257627 47087 25356
Total 4233868 5377012 694303 112494 64122
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ters, and hence postexposure prophylaxis (PEP) (Krebs
et al., 1998). Approximately 20,000 to 40,000 people annu-
ally receive PEP in the U.S., and even a single rabid animal
may potentially expose hundreds of people, resulting in mil-
lions of dollars for biologicals alone (Noah et al., 1996). The
most recent estimate for the cost of PEP and indirect patient
costs of receiving treatment is about $3350 ($2250 PEP and
$1100 indirect costs) (Shwiff et al., 2003). This cost does
not take into account other indirect costs, many of which are
borne by municipal, county, state and federal agencies re-
sponsible for rabies control. The overall cost of living with
all strains of rabies in the U.S. has been conservatively esti-
mated to be $300 million/year (Krebs et al., 1995).
Application of coordinated ORV to prevent raccoon rabies
from spreading beyond its current distribution appears cost-
beneficial based on the robust economic analysis (Kemere
et al., 2002). However, future analyses need to more realisti-
cally model spatial scenarios for the spread of raccoon rabies
in the absence of ORV intervention as well as address other
assumptions that facilitated this analysis. Moreover, elimi-
nation strategies that are designed to create rabies free areas
where the virus has been established will require sufficient
resources to leave immune buffers to prevent spread to new
areas. The economic dynamic of such a strategy has not been
evaluated in detail. Given that costs are and will remain a
central issue to ORV, the National Economic Team has pro-
vided guidance and recommended funding for five economic
analyses or related modeling studies to better characterize
the economic dynamics of rabies and rabies control and the
associated risks in the absence of intervention. The team will
continue to consider how to best approach economic analyses
for elimination strategies.
The goals of containing and eliminating specific variants
of the rabies virus require strategic application of the limited
resources available for ORV. Even when applied in combina-
tion with effective natural barriers and enhanced surveillance,
progress may be expected in reasonably small increments
along portions of the barrier, as federal and cooperator funds
are not likely to become available to treat entire regions in
single baiting campaigns. In 2003, almost 111,000 km2 were
treated for raccoon rabies (Table 2). This is a substantial ac-
complishment toward containing raccoon rabies, but to have
a better chance for sustained and perhaps increased access to
federal and state resources, more rapid successes are needed
to demonstrate that elimination of raccoon rabies is practical.
This accomplishment would result in freeing resources com-
mitted to areas currently being treated such that they may be
applied in new areas requiring vaccination.
4. Collaboration and cooperation among Canada,
Mexico and the United States
To achieve rabies management goals, cooperation, coor-
dination and collaboration are required among Canada, Mex-
ico, and the U.S. Spillover of canine rabies, enzootic in Mex-
ico, into coyotes and the subsequent outbreak in south Texas
in the 1990s (CDC, 1995); spread of rabies in red foxes into
northern New York and New England as recently as the early
1990s (Trimarchi, 1991); movement of the raccoon variant
of rabies virus into southern Ontario in 1999 (Rosatte et al.,
2001); and the movement of raccoon rabies into eastern New
Brunswick in 2000 (Allen, pers. com.) are recent events that
underscore the need for a viable North America Rabies Man-
agement Plan. Currently, APHIS-WS has an extended Envi-
ronmental Assessment that serves, in large part, as a national
ORV plan. This document, along with APHIS-WS Rabies
Business Plan and other key national efforts such as the plan-
ning process conducted at CDC beginning in the early 1990s
covering the broader spectrum of rabies issues (Hanlon et al.,
1999a,b,c—Special Series Articles I, II and III), will serve
as foundation references to solidify a National Plan within
the NEPA process (NEPA, 1969). The National Rabies Man-
agement Plan will in turn allow for integration of input from
Canada and Mexico to form the basis for the North American
Rabies Management Plan.
5. Conclusions
Progress has been made in applying ORV to contain and
eliminate some strains of terrestrial rabies in North America.
Notable examples include near elimination of rabies from
red foxes in southern Ontario (MacInnes et al., 2001), con-
tainment and elimination of canine rabies in coyotes from
south Texas (Fearneyhough et al., 1998; Sidwa, pers. com.),
containment and near elimination of raccoon rabies from
Ohio (Krebs et al., 2002), prevention of raccoon rabies spread
through the Lake Champlain Valley in New York and across
northern Vermont and New Hampshire (Bigler, pers. com.)
and reduced incidence of rabies cases where other sizable
ORV projects targeting raccoons have occurred (Krebs et al.,
2002). In February 2004, raccoon rabies was detected on the
oceanside of the Cape Cod Canal, an anchor point for an ORV
effort that began in 1994. Contingency baiting and TVR have
been implemented to attempt to contain this expanded spread
of raccoon rabies. In 2003, there were 23 cases in the Cape
Cod ORV barrier, suggesting a formidable epizootic chal-
lenge to the barrier, which ranged in width from 5 to 29 km.
Both Ontario and New Brunswick have been raccoon rabies-
free for greater than 10 months and 2 years, respectively,
after implementation of “point infection control” strategies
(Rosatte et al., 2001), but continued surveillance is critical
to monitor project effectiveness. An ORV zone established
in northwest Georgia, southeast Tennessee, and northeast Al-
abama in 2003 was in response to enhanced surveillance sug-
gesting that intervention with ORV was the prudent action to
prevent raccoon rabies moving westward.
Many challenges have been identified. Initiatives have
been taken toward: evaluation and development of new, more
effective oral vaccines and baits; a more comprehensive un-
derstanding of rabies reservoir species population structure
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and dynamics in relation to ORV strategies; reduced translo-
cation of rabies reservoir species; an applied understanding
of the economic costs and benefits of ORV intervention; and
enhanced coordination on rabies control in North America.
New challenges will arise, emphasizing the critical niche that
is filled by the interdisciplinary Rabies Management Team in
planning future program direction.
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